Glucose-lowering drugs and cardiovascular risk: how recent outcome trials have informed practice
Although large clinical trials with glucose-lowering drugs have consistently shown beneficial reductions in microvascular complications, their effects on macrovascular complications have been controversial. Interpreting these trials is complicated by substantial differences in their design, the…